Video

Address Patients’ Specific Concerns About Second COVID-19 Vaccine Dose

In addition to overall concerns about COVID-19 vaccines patients may have stronger fears about the second vaccine dose since it is often accompanied with more adverse effects.

Related Videos
California Wildfires, Pharmacies, Community | image Credit: J Bettencourt/peopleimages.com | stock.adobe.com
California Wildfire, Pharmacy, Community | Image Credit: Erin | stock.adobe.com
Allergies, Asthma, Biologic Treatment, Pharmacists | Image Credit: Pixel-Shot | stock.adobe.com
Woman professional nutritionist checking dietary supplements in hand, surrounded by a variety of fruits, nuts, vegetables, and dietary supplements on the table - Image credit: amenic181 | stock.adobe.com
Related Content
Drug Prices, Ozempic, Biktarvy | Image Credit: lucid_dream | stock.adobe.com
January 21st 2025

Ozempic, Biktarvy Among the Drugs Seeing List Price Increases at the Start of 2025

Ashley Gallagher, Editor
Public Health Matters: The Importance of Reproductive Justice and Black Maternal Health
December 24th 2024

Public Health Matters: The Importance of Reproductive Justice and Black Maternal Health

Christina M. Madison, PharmD, FCCP, AAHIVP
Teenager stepping on scale -- Image credit: Africa Studio | stock.adobe.com
January 21st 2025

Study Finds Structural Differences of Brain Associated With Eating Disorders, Harmful Eating Habits

Gillian McGovern, Associate Editor
Pharmacy Focus: Oncology Edition – Key Insights and Interviews From the 2024 SABCS Meeting
December 23rd 2024

Pharmacy Focus: Oncology Edition – Key Insights and Interviews From the 2024 SABCS Meeting

Alexandra Gerlach, Associate Editor
Cardiovascular Disease, Polypill, Affordability, Adherence | Image Credit: santoelia | stock.adobe.com
January 21st 2025

Polypill Treatment for Cardiovascular Disease Shows Affordability for Majority Black Populations

Ashley Gallagher, Editor
Bispecific antibodies | Image Credit: © Александр Михайлюк - stock.adobe.com
January 21st 2025

KN026 and Docetaxel Show Promise as First-Line Treatment for HER2+ Metastatic Breast Cancer

Alexandra Gerlach, Associate Editor